Active Recombinant Human HHLA2

• Cat.No.: HHLA2-69H
• Product Overview: Recombinant Human HHLA2 was expressed in HEK293 Cells.

Specification

• Source: HEK293 Cells
• Species: Human
• Predicted N Terminal: Ile23
• Form: Lyophilized from a 0.2 µm filtered solution in PBS.
• Bio-activity: Measured by its ability to inhibit anti-CD3 antibody induced IL-2 secretion in human T lymphocytes. The ED50 for this effect is typically 2-10 µg/mL.
• Molecular Mass: 64 kDa (monomer)
• Purity: >90%, by SDS-PAGE under reducing conditions and visualized by silver stain.
• Storage: Avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 3 months, -20 to -70 °C under sterile conditions after reconstitution.
• Reconstitution: Reconstitute at 100 µg/mL in PBS.

Gene Information

• Gene Name: HHLA2 HERV-H LTR-associating 2 [ Homo sapiens (human) ]
• Official Symbol: HHLA2
• Synonyms: HHLA2; B7H7; HERV-H LTR-associating 2; HERV-H LTR-associating protein 2; human endogenous retrovirus-H long terminal repeat-associating protein 2
• Gene ID: 11148
• mRNA Refseq: NM_007072
• Protein Refseq: NP_009003
• MIM: 604371
• UniProt ID: Q9UM44
• Chromosome Location: 3q13.13
• Function: molecular_function